Sanofi's Aubagio wins EU nod for multiple sclerosis

09/3/2013 | PharmaTimes (U.K.)

The European Commission has approved Sanofi's Aubagio, or teriflunomide, for treatment of adults with relapsing remitting multiple sclerosis. The approval, based on favorable data from two late-stage studies, followed a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use.

View Full Article in:

PharmaTimes (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX